拉莫三嗪(CAS 84057-84-1):分子式 C9H7Cl2N5、分子量 256.09。
| CAS号 | 84057-84-1 |
|---|---|
| 分子式 | C9H7Cl2N5 |
| 分子量 | 256.09 |
| 熔点 | 177-181 |
| 沸点 | 503.1±60.0 |
| LogP | 1.93 |
| 应用领域 | Uses: MEDICATION、Anticonvulsants、Calcium Channel Blockers、Excitatory Amino Acid Antagonists、Voltage-Gated Sodium Channel Blockers、Use (kg) in Switzerland (2009): >1000、Use (kg、approx.) in Germany (2009): >7500、Use (kg) in USA (2002): 10500、Consumption (g per capita) in Switzerland (2009): 0.13、Consumption (g per capita、approx.) in Germany (2009): 0.092、Consumption (g per capita) in the USA (2002): 0.037、Excretion rate: 0.1、Calculated removal (%): 11、For the adjunctive treatment of partial seizures in epilepsy and generalized seizures of Lennox-Gastaut syndrome. Also for the maintenance treatment of bipolar I disorder and depression. Off-label uses include the treatment of peripheral neuropathy、trigeminal neuralgia、cluster headaches、migraines、and reducing neuropathic pain. (A308、L1155)、Use Classification: Pharmaceuticals、Methods of Manufacturing: Reaction of 2、3-dichlorobenzoyl chloride with cyanide ion forms the benzoylcyanide derivative that is then treated with aminoguanidine to form a Schiff base through loss of water between the carbonyl group and the one primary amine function of the guanidine. Ring closure by addition of the lone free primary amino group remaining on the guanidine moiety of the nitrile function is accomplished by base catalysis and yields the product.、The reaction of the Grignard compound of 2、3-dichloroiodobenzene with CO2 in diethyl ether gives 2、3-dichlorobenzoic acid、which is converted to the corresponding acyl chloride by refluxing with SOCl2. The reaction of 2、3-dichlorobenzoyl chloride with cuprous cyanide and KI in refluxing xylene yields 2、3-dichlorobenzoyl cyanide. Finally、this compound is cyclized with aminoguanidine in DMSO to yield lamotrigine.、Hydrogenation of 2、3-dichloronitrobenzene with H2 over Raney nickel in methanol gives 2、3-dichloroaniline、which is diazotized with NaNO2 and HCl and treated with CuCN to yield 2、3-dichlorobenzonitrile. Hydrolysis of the nitrile with NaOH in refluxing methanol、water affords 2、which is treated with hot SOCl2 to provide the corresponding acyl chloride. Reaction of 2、3-dichlorobenzoyl chloride with CuCN and KI in refluxing chlorobenzene gives 2、3-dichlorobenzoyl cyanide、which is condensed with aminoguanidine by means of H2SO4、TsOH in hot toluene to yield 2、3-dichlorobenzoyl cyanide amidinohydrazone. Finally、this compound is cyclized by treatment with NaOMe in refluxing methanol to yield lamotrigine.、Preparation: M. G. Baxter et al.、European Patent Office patent 21121 (1981 to Wellcome Foundation)、D. A. Sawyer et al.、USA patent 4602017 (1986).、Formulations、Preparations: Table: Lamotrigine Preparations [Table#7220] |
登记用途:Uses: MEDICATION、Anticonvulsants、Calcium Channel Blockers、Excitatory Amino Acid Antagonists、Voltage-Gated Sodium Channel Blockers、Use (kg) in Switzerland (2009): >1000、Use (kg、approx.) in Germany (2009): >7500、Use (kg) in USA (2002): 10500、Consumption (g per capita) in Switzerland (2009): 0.13、Consumption (g per capita、approx.) in Germany (2009): 0.092、Consumption (g per capita) in the USA (2002): 0.037、Excretion rate: 0.1、Calculated removal (%): 11、For the adjunctive treatment of partial seizures in epilepsy and generalized seizures of Lennox-Gastaut syndrome. Also for the maintenance treatment of bipolar I disorder and depression. Off-label uses include the treatment of peripheral neuropathy、trigeminal neuralgia、cluster headaches、migraines、and reducing neuropathic pain. (A308、L1155)、Use Classification: Pharmaceuticals、Methods of Manufacturing: Reaction of 2、3-dichlorobenzoyl chloride with cyanide ion forms the benzoylcyanide derivative that is then treated with aminoguanidine to form a Schiff base through loss of water between the carbonyl group and the one primary amine function of the guanidine. Ring closure by addition of the lone free primary amino group remaining on the guanidine moiety of the nitrile function is accomplished by base catalysis and yields the product.、The reaction of the Grignard compound of 2、3-dichloroiodobenzene with CO2 in diethyl ether gives 2、3-dichlorobenzoic acid、which is converted to the corresponding acyl chloride by refluxing with SOCl2. The reaction of 2、3-dichlorobenzoyl chloride with cuprous cyanide and KI in refluxing xylene yields 2、3-dichlorobenzoyl cyanide. Finally、this compound is cyclized with aminoguanidine in DMSO to yield lamotrigine.、Hydrogenation of 2、3-dichloronitrobenzene with H2 over Raney nickel in methanol gives 2、3-dichloroaniline、which is diazotized with NaNO2 and HCl and treated with CuCN to yield 2、3-dichlorobenzonitrile. Hydrolysis of the nitrile with NaOH in refluxing methanol、water affords 2、which is treated with hot SOCl2 to provide the corresponding acyl chloride. Reaction of 2、3-dichlorobenzoyl chloride with CuCN and KI in refluxing chlorobenzene gives 2、3-dichlorobenzoyl cyanide、which is condensed with aminoguanidine by means of H2SO4、TsOH in hot toluene to yield 2、3-dichlorobenzoyl cyanide amidinohydrazone. Finally、this compound is cyclized by treatment with NaOMe in refluxing methanol to yield lamotrigine.、Preparation: M. G. Baxter et al.、European Patent Office patent 21121 (1981 to Wellcome Foundation)、D. A. Sawyer et al.、USA patent 4602017 (1986).、Formulations、Preparations: Table: Lamotrigine Preparations [Table#7220]。
拉莫三嗪 是一种化工化合物,登记 CAS 号为 84057-84-1,分子式 C9H7Cl2N5(分子量 256.09)。
登记 CAS 号:84057-84-1
其分子式 C9H7Cl2N5 由 9 个碳、7 个氢、2 个氯、5 个氮 组成。
别名/同义词:拉莫三嗪 · Lamotrigine
拉莫三嗪 的 CAS 登记号为 84057-84-1。
分子式 C9H7Cl2N5,分子量 256.09。
别名/同义词:拉莫三嗪、Lamotrigine。
登记用途:Uses: MEDICATION、Anticonvulsants、Calcium Channel Blockers、Excitatory Amino Acid Antagonists、Voltage-Gated Sodium Channel Blockers、Use (kg) in Switzerland (2009): >1000、Use (kg、approx.) in Germany (2009): >7500、Use (kg) in USA (2002): 10500、Consumption (g per capita) in Switzerland (2009): 0.13、Consumption (g per capita、approx.) in Germany (2009): 0.092、Consumption (g per capita) in the USA (2002): 0.037、Excretion rate: 0.1、Calculated removal (%): 11、For the adjunctive treatment of partial seizures in epilepsy and generalized seizures of Lennox-Gastaut syndrome. Also for the maintenance treatment of bipolar I disorder and depression. Off-label uses include the treatment of peripheral neuropathy、trigeminal neuralgia、cluster headaches、migraines、and reducing neuropathic pain. (A308、L1155)、Use Classification: Pharmaceuticals、Methods of Manufacturing: Reaction of 2、3-dichlorobenzoyl chloride with cyanide ion forms the benzoylcyanide derivative that is then treated with aminoguanidine to form a Schiff base through loss of water between the carbonyl group and the one primary amine function of the guanidine. Ring closure by addition of the lone free primary amino group remaining on the guanidine moiety of the nitrile function is accomplished by base catalysis and yields the product.、The reaction of the Grignard compound of 2、3-dichloroiodobenzene with CO2 in diethyl ether gives 2、3-dichlorobenzoic acid、which is converted to the corresponding acyl chloride by refluxing with SOCl2. The reaction of 2、3-dichlorobenzoyl chloride with cuprous cyanide and KI in refluxing xylene yields 2、3-dichlorobenzoyl cyanide. Finally、this compound is cyclized with aminoguanidine in DMSO to yield lamotrigine.、Hydrogenation of 2、3-dichloronitrobenzene with H2 over Raney nickel in methanol gives 2、3-dichloroaniline、which is diazotized with NaNO2 and HCl and treated with CuCN to yield 2、3-dichlorobenzonitrile. Hydrolysis of the nitrile with NaOH in refluxing methanol、water affords 2、which is treated with hot SOCl2 to provide the corresponding acyl chloride. Reaction of 2、3-dichlorobenzoyl chloride with CuCN and KI in refluxing chlorobenzene gives 2、3-dichlorobenzoyl cyanide、which is condensed with aminoguanidine by means of H2SO4、TsOH in hot toluene to yield 2、3-dichlorobenzoyl cyanide amidinohydrazone. Finally、this compound is cyclized by treatment with NaOMe in refluxing methanol to yield lamotrigine.、Preparation: M. G. Baxter et al.、European Patent Office patent 21121 (1981 to Wellcome Foundation)、D. A. Sawyer et al.、USA patent 4602017 (1986).、Formulations、Preparations: Table: Lamotrigine Preparations [Table#7220]。
拉莫三嗪(CAS 84057-84-1)的独立参考数据,整理自公开化学数据库。
| CAS 号 | 84057-84-1 |
|---|---|
| PubChem CID | 3878 |
| 分子式 | C9H7Cl2N5 |
| IUPAC 名称 | 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine |
| UNII(FDA) | U3H27498KS |
| Molecular Weight | 256.09 |
|---|---|
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 1 |
| Exact Mass | 255.0078506 |
| Monoisotopic Mass | 255.0078506 |
| Topological Polar Surface Area | 90.7 |
| Heavy Atom Count | 16 |
| Boiling Point | 503.1±60.0 |
|---|---|
| Melting Point | 177-181 |
| Melting Point | 216-218 °C (uncorr) |
| Melting Point | 216 - 218 °C (uncorr.) |
| Solubility | 0.17 |
| Solubility | In water, 170 mg/L at 25 °C |
| Solubility | 4.88e-01 g/L |
| LogP | 1.93 |
| LogP | log Kow = 2.57 |
| LogP | 2.5 |
lamotrigine; 84057-84-1; 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine; Lamictal; Lamictal Cd; Lamotrigina; Lamictal XR; Lamotriginum; BW 430C; 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine; BW-430C; Lamictal ODT; 1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-; 3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine; DTXSID2023195; BW430C
| 已通报的危害声明 | H301 (100%), H412 (19.1%), H319 (100%), H336 (100%), H361 (100%), H362 (100%), H410 (100%) |
|---|
拉莫三嗪 · CAS 84057-84-1 · C9H7Cl2N5. UNII U3H27498KS. Boiling Point: 503.1±60.0; Melting Point: 177-181; Melting Point: 216-218 °C (uncorr).
数据来源:PubChem / Wikidata;与随货 COA 不一致时以 COA 为准。
English page: Lamotrigine